Respuesta :
Studies and research have shown cyclophosphamide to be a promising therapy for patients with multiple myeloma. However, given the intensive of the therapy, there is a strong risk of serious complications. The most prevalent of these is high-grade neutropenia, which can leave the patient extremely susceptible to infections.
Answer:
The correct answer is "Acute myelogenous leukemia".
Explanation:
The missing options of this question are:
Kaposi sarcoma
Burkitt's lymphoma
Squamous cell carcinomas
Acute myelogenous leukemia
The correct answer is "Acute myelogenous leukemia".
Acute myelogenous leukemia (AML) is a type of cancer that goes into the blood and bone marrow, characterized for being of a rapid progression. This condition is widely acquired by patients that are suffering from multiple myeloma. Therefore, it is very important to monitor and treat patients with multiple myeloma before they develop AML.